MA11.07 Phase 1/2 TRIDENT-1 Study of Repotrectinib in Patients with ROS1+ or NTRK+ Advanced Solid Tumors
| Autor: | Cho, B.C., Doebele, R.C., Lin, J., Nagasaka, M., Baik, C., Van Der Wekken, A., Velcheti, V., Lee, K.H., Liu, S., Solomon, B., Kao, S., Krebs, M.G., Zhu, V., Stopatschinskaja, S., Camidge, R., Drilon, A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2021 16(3) Supplement:S174-S175 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|